Literature DB >> 17506514

Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.

Antonia Miranda1, Mónica Millán, Isidoro Caraballo.   

Abstract

In previous papers of our research group, a linear relationship between the drug percolation threshold and the relative drug particle size (drug/excipient) has been found, in the case of the inert matrices. The objective of the present paper is to investigate the influence of the particle size on the excipient percolation threshold in the case of hydrophilic matrices. This influence can have important consequences on the release behaviour of these controlled release devices. Matrix tablets have been prepared using KCl/Lobenzarit Disodium as drugs and HPMC K4M as matrix forming material, employing six different excipient/drug particle size ratios (ranging from 0.42 to 4.16). The formulations studied contain a drug loading in the range of 20-90% (w/w). In order to estimate the percolation threshold, the behaviour of the kinetic parameters with respect to the volumetric fraction of each component at time zero, was studied. The obtained results support the existence of a linear relationship between a component percolation threshold (drug or excipient) and its relative particle size (drug/excipient in the case of the drug percolation threshold or excipient/drug in the case of the excipient percolation threshold). This relationship is valid for different drugs, excipients and systems (inert or hydrophilic matrix tablets). (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506514     DOI: 10.1002/jps.20912

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl.

Authors:  Tamara Gonçalves-Araújo; Ali R Rajabi-Siahboomi; Isidoro Caraballo
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Characterising Drug Release from Immediate-Release Formulations of a Poorly Soluble Compound, Basmisanil, Through Absorption Modelling and Dissolution Testing.

Authors:  Cordula Stillhart; Neil J Parrott; Marc Lindenberg; Pascal Chalus; Darren Bentley; Anikó Szepes
Journal:  AAPS J       Date:  2017-02-24       Impact factor: 4.009

Review 3.  An overview on in situ micronization technique - An emerging novel concept in advanced drug delivery.

Authors:  K R Vandana; Y Prasanna Raju; V Harini Chowdary; M Sushma; N Vijay Kumar
Journal:  Saudi Pharm J       Date:  2013-05-29       Impact factor: 4.330

4.  Polymer Percolation Threshold in Multi-Component HPMC Matrices Tablets.

Authors:  Maryam Maghsoodi; Leila Barghi
Journal:  Adv Pharm Bull       Date:  2011-07-20

Review 5.  Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Authors:  Susan Hua; Ephraem C Lye
Journal:  Drug Deliv Transl Res       Date:  2022-05-18       Impact factor: 4.617

6.  The impact of dose and solubility of additives on the release from HPMC matrix tablets--identifying critical conditions.

Authors:  Farhad Tajarobi; Susanna Abrahmsén-Alami; Magnus Hansen; Anette Larsson
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

7.  Formulation and characterization of a plasma sterilized, pharmaceutical grade chitosan powder.

Authors:  Andrew R Crofton; Samuel M Hudson; Kristy Howard; Tyler Pender; Abdelrahman Abdelgawad; Daniel Wolski; Wolff M Kirsch
Journal:  Carbohydr Polym       Date:  2016-03-06       Impact factor: 9.381

Review 8.  Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.